Viewing Study NCT06540066

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 4:31 PM
Ignite Modification Date: 2026-01-31 @ 1:39 PM
Study NCT ID: NCT06540066
Status: RECRUITING
Last Update Posted: 2025-11-20
First Post: 2024-08-02
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Study of BGB-B3227 Alone and in Combination With Tislelizumab in Participants With Advanced or Metastatic Solid Tumors
Sponsor: BeiGene
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Advanced Cancer View
None Advanced Solid Tumor View
None Metastatic Cancer View
None Metastatic Solid Tumor View
Keywords:

Keywords

Keyword Brief Keyword Text View
None BGB-B3227 View
None tislelizumab View
None BGB-A317 View
None advanced solid tumor View
None metastatic solid tumor View